|Articles|February 19, 2016
Translational Medicine: A “Team Sport”?
Author(s)DIA
February 19, 2016
Advertisement
Dr. Makoto Suematsu, President of the Japan Agency for Medical Research & Development (AMED); and Dr. Christopher P. Austin, Director of the National Center for Advancing Translational Sciences (NCATS), US National Institutes of Health; discuss how collaboration between their agencies will ultimately deliver better therapies more quickly to more patients.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5